Document is current

Any future updates will be listed below

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis

Crossref DOI link: https://doi.org/10.1007/s40744-022-00439-8

Published Online: 2022-03-18

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark